Showing results (171-180 of 395) with videos related to
Sort By:
Pageof 40
AJNR. American Journal of Neuroradiology|July 12, 2024
Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with IDH-Mutant GliomaLucia Nichelli, Capucine Cadin, Patrizia Lazzari, et al.Neoplasia (New York, N.Y.)|February 23, 2012
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningiomaHong Wei Yang, Tae-Min Kim, Sydney S Song, et al.Journal of Neuro-Oncology|May 29, 2004
Loss of 14q chromosome in oligodendroglial and astrocytic tumorsCharles Dichamp, Sophie Taillibert, Lucinda Aguirre-Cruz, et al.Biomed Research International|May 31, 2014
IDH mutations: genotype-phenotype correlation and prognostic impactXiao-Wei Wang, Pietro Ciccarino, Marta Rossetto, et al.Journal of Neuro-Oncology|May 29, 2004
Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumorsLucinda Aguirre-Cruz, Karima Mokhtari, Khê Hoang-Xuan, et al.Cancer Genetics and Cytogenetics|December 19, 2006
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastomaElodie Vauleon, Nathalie Auger, Alexandra Benouaich-Amiel, et al.Journal of Neuro-Oncology|June 15, 2007
No association of MDM2 SNP309 with risk of glioblastoma and prognosisSoufiane El Hallani, Yannick Marie, Ahmed Idbaih, et al.European Radiology|March 31, 2021
Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomasArnaud Pellerin, Maya Khalifé, Marc Sanson, et al.Journal of Neuro-Oncology|March 29, 2021
Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohortTuan Le Van, Thomas Graillon, Julian Jacob, et al.Journal of Neuro-Oncology|January 9, 2010
Up-front temozolomide in elderly patients with glioblastomaFlorence Laigle-Donadey, Dominique Figarella-Branger, Olivier Chinot, et al.Pageof 40